Northwest Biotherapeutics (OTCMKTS:NWBO) stock is trading with moderate gains on Monday’s trading session.
Market Action
As of 12:28, NWBO stock gained 3.68% at $1.69. The stock has traded 1.35 million shares, compared to its average volume of 2.04 million shares. The stock opened at $1.64 and moved in a range of $1.6200 – 1.7200.
NWBO Business Description
Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient’s own immune system to attack cancer.
Its lead product, DCVax-L that is in Phase III clinical trials to treat Glioblastoma multiforme brain cancer. The company also develops DCVax-Direct, which is in Phase I/II clinical trials to treat inoperable solid tumors. The company was founded in 1996 and is headquartered in Bethesda, Maryland.
Trader Notes
Share Information
| SHARES OUTSTANDING | 842.29 M |
| SHARE FLOAT (%) | 810.07 M (96.17%) |
| % HELD BY INSTITUTIONS | 0.05 |
Recent Stock Performance
| 5-DAY PERF. | -13.33% |
| 1-MONTH PERF. | +13.42% |
| 3-MONTH PERF. | +12.67% |
| 6-MONTH PERF. | +35.20% |
| YTD PERF. | +10.82% |
| 1-YEAR PERF. | +409.04% |
Moving Averages
| +/- EMA(20) | 1.56 (+8.33%) |
| +/- SMA(50) | 1.50 (+12.67%) |
| +/- SMA(200) | 1.26 (+34.13%) |
Pivot Points
| Name | S3 | S2 | S1 | Pivot Points | R1 | R2 | R3 |
| Classic | 1.5200 | 1.5500 | 1.5900 | 1.6200 | 1.6600 | 1.6900 | 1.7300 |
| Fibonacci | 1.5500 | 1.5767 | 1.5933 | 1.6200 | 1.6467 | 1.6633 | 1.6900 |
Technical Indicators
| Symbol | Value | Result | Symbol | Value | Result |
| ADX | 22.1380 | Neutral | ATR14 | 0.1446 | |
| CCI20 | 59.3414 | Buy | Chaikin Money Flow | 0.0910 | Buy |
| MACD | 0.0598 | Buy | Money Flow Index | 63.5647 | Buy |
| ROC | 14.7887 | Buy | RSI | 55.2697 | Sell |
| STOCH (14,3) | 35.0000 | Sell | STOCH RSI | 0.0930 | OverSold |
| UO | 48.7971 | Sell | Williams %R | -65.0000 | Neutral |
){kind=link}